Mivebresib (ABBV-075)
Product Specifications
CAS Number
1445993-26-9
Target
Epigenetic Reader Domain
Applications
Epigenetics
Smiles
CCS (=O) (=O) NC1=CC (=C (C=C1) OC2=C (C=C (C=C2) F) F) C3=CN (C (=O) C4=C3C=CN4) C
Molecular Formula
C22H19F2N3O4S
Additionnal Information
Mivebresib (ABBV-075) is a novel BET family bromodomain inhibitor. It binds bromodomains of BRD2/4/T with similar affinities (Ki of 1-2.2 nM) and highly selective for 18 bromodomain proteins tested (Kd > 1 μM; more than 600-fold selectivity vs. BRD4), but exhibits roughly 10-fold weaker potency towards BRD3 (Ki of 12.2 nM) and has moderate activity towards CREBBP (Kd = 87 μM; 54-fold selectivity vs. BRD4) . Mivebresib (ABBV-075) efficiently triggers apoptosis in various tumor cell.
Storage Conditions
2 years -80 in solvent
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
P4258-11 10 µg
Platelet Derived Growth Factor AB, Recombinant, Human (PDGF-AB, PDGF alpha, beta Polypeptide, Becaplermin, Heterodimer Platelet-derived Growth Factor, Glioblastoma-derived T-cell Suppressor Factor, BSC-1 Cell Growth Inhibitor, Polyergin, Cetermin, TGFB2, Transforming Growth Factor beta-2, SIS, c-sis) discontinued
Sign In for Pricing
View Details 
248076-HRP 100 µL
LASS4 (LAG1 Homolog, Ceramide Synthase 4, CerS4, FLJ12089, Trh1) (HRP)
Sign In for Pricing
View Details 